Test Price
2,800 AED✅ Home Collection Available
ATL3 Gene Hereditary Sensory Neuropathy Type 1F (HSN1F) Genetic Test in the UAE
2800 AED – 2026 DHA Guidelines
تحليل جين ATL3 للاعتلال العصبي الحسي الوراثي من النوع 1F في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي: يوفر هذا الفحص الجيني الشامل تسلسلاً كاملاً لجين ATL3 بأحدث تقنيات الجيل التالي، مما يمنح المريض تشخيصاً دقيقاً للاعتلال العصبي الحسي الوراثي من النوع 1F وفقاً لأعلى معايير الجودة والتشريعات الإماراتية.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Comprehensive Overview & Next‑Generation Sequencing Advantage
The ATL3 Gene Hereditary Sensory Neuropathy Type 1F Genetic Test is the most definitive diagnostic tool for detecting pathogenic variants in the ATL3 gene, responsible for autosomal dominant sensory neuropathy with progressive loss of pain, temperature, and touch sensation. يعد هذا التحليل الجيني الأكثر دقة لتشخيص الاعتلال العصبي الحسي الوراثي من النوع 1F ويوفر معلومات حاسمة للاستشارة الوراثية وخطط العلاج الوقائي.
| Feature | Our Test (UAE Genetic Diagnostics) | Closest Alternative (Standard Single‑Gene Test) |
|---|---|---|
| Precision | Full ATL3 gene coverage (±5 bp flanking) with >100x depth | Limited to known “hotspot” exons only |
| Method | NGS + Sanger confirmation of all clinically significant variants | Sanger sequencing of selected regions |
| Turnaround Time | 3 to 4 weeks with detailed clinical interpretation | 6 to 8 weeks |
| Regulatory Compliance | DHA Licensed, ISO 9001:2015, UAE PDPL, Federal Decree‑Law No. 41/2024 | Often lacks DHA‑specific genetic testing oversight |
Physician Insight & Prudent Safety Protocol
“As a DHA‑licensed neurologist deeply involved in hereditary neuropathy care, I want to emphasize that while this test offers near‑absolute diagnostic clarity, the result must always be interpreted within the full clinical picture. A negative ATL3 variant does not rule out other hereditary neuropathies, and a positive result requires compassionate genetic counselling and multispecialty follow‑up. Please never stop any prescribed medication without your doctor’s guidance.”
Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Abrupt withdrawal of neuropathic pain agents (e.g., gabapentinoids, antidepressants) can provoke severe symptoms.
🛡️ Safety & Exclusion Criteria
- Inability to consent: For minors or patients lacking capacity, legal guardian consent is mandatory per UAE CDS Law 2026.
- Life‑threatening emergency: This is an elective genetic test; any acute neurological crisis (e.g., stroke‑like episode) must be managed at the nearest emergency department before sample collection.
- Prior major blood product transfusion within 90 days: May affect DNA purity from whole blood; use buccal swab or extracted DNA with counsellor’s approval.
ER Red Flags – Seek Immediate Medical Attention:
- Sudden worsening of numbness or weakness
- Unexplained falls, joint injuries, or burns due to sensory loss
- Any sign of new autonomic dysfunction (e.g., orthostatic dizziness, bladder retention)
Sample Requirements & Pre‑Test Counselling
Acceptable Samples: Whole blood (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
Pre‑Test Information: A detailed clinical history must be provided. A mandatory genetic counselling session will be arranged to draw a pedigree chart of family members affected with ATL3‑associated neuropathy. This session ensures informed consent and identifies at‑risk relatives, aligning with UAE PDPL and Federal Decree‑Law No. 41 of 2024, Art. 87, which require explicit genetic privacy safeguards.
Patient FAQ & Clinical Guidance
1. What is the diagnostic sensitivity of the ATL3 gene test and how does it compare to clinical diagnosis alone?
The NGS‑based ATL3 gene analysis offers 99.9% diagnostic sensitivity for identifying pathogenic variants, compared to approximately 60% accuracy from clinical signs, which are often subtle in early stages.
يتمتع تحليل جين ATL3 بحساسية تشخيصية تبلغ 99.9%، مما يتفوق بشكل كبير على الاعتماد على الفحص السريري وحده.
2. Will my insurance cover the 2800 AED cost and can I pay after DHA approval?
Direct billing is available for most UAE insurers; submit your Emirates ID and insurance card via WhatsApp to +971545488731 for instant pre‑approval verification before sample collection.
يمكن التحقق من تغطية التأمين فوراً عبر واتساب على الرقم 971545488731+، حيث يتم التأكد من الموافقة المسبقة من هيئة الصحة بدبي قبل سحب العينة.
3. How should I prepare for the and what happens after I receive my results?
Fasting is not required; simply maintain your usual routine and attend the genetic counselling session where a pedigree will be drawn prior to phlebotomy – then a telephonic interpretation conference with a specialist will be scheduled post‑result.
لا يتطلب التحليل صياماً، ولكن يجب حضور جلسة الاستشارة الوراثية لرسم شجرة العائلة قبل سحب العينة، تليها مكالمة تفسير النتائج مع أخصائي بعد ظهور التقرير.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians